ICI Meeting 2018 – the premier International Conference for Innovations in Cardiovascular Systems (Heart, Brain and Peripheral Vessels) and High-Tech Life Science Industry, was held this year in Tel Aviv, Israel, December 2-4, 2018.

The ICI Meeting is an acclaimed forum which explores the innovations that will shape the future of cardiovascular systems. Over the last 2 decades, Israel has become a medical “start-up nation”.  ICI has contributed to this process by facilitating global interactions between physicians, entrepreneurs, academia and industry.

Rutie Adar, Director and Head of Samsung Strategy and Innovation Center inIsrael participated in a panel that was held during the “Digital Health Day” and was dedicated to the subject of “How to monetize your product”. The moderators were:

·         Michal Geva, Founder and Managing Partner, TriVentures

·         Peter Fitzgerald, Director of the Center for Cardiovascular Technology at Stanford University.

Other participants included: Lee Shapiro, Managing Partner, 7wireventures, Mike Philips, Chief Information & Innovation Officer at Intermountain Health, Netalie Nadivi, Partner, TriVentures and Noam Gabison, Head of Digital Health, Facebook Israel.

Shapiro, talked about the potential disruption of digital health to the market, and the fact that developing a digital health solution is much faster than a digital device that needs to go through many level of clinical trials. On the other hand, he described the challenges the healthcare system faces in adopting new technologies and changing people behaviors. He brought to the table some start-up success stories, such as Livongo, which uses data to help human change behavior and achieve clinical results that make an impact in the treatment of chronic diseases.

Philips, talked about how important it is to have a new technology platform approach and not a set of narrow solutions. He talked about a ‘transformational change’ rather than ‘adoption of one tool or another’ to transform the overall healthcare system.

Nadivi described the huge scale of data held in Israel, where many millions of patient data has been collected for over 20 years and is becoming accessible to companies to gain new insights. She described the local eco-system in Israel that has both a medical and IT background and is in a great position to leverage the data.

Gabison talked about the importance of adding personal context to the medical data, for example, the emotional state of a person influences his condition, how well he will adhere to the treatment, and even how effective any treatment will be.

“Technology is transforming the lives of patients, caregivers, and healthcare providers. The healthcare industry is ready for disruption”, said Adar, “Samsung will be at the forefront of the movement, giving people more information about their health, and more control over their care.

According to Adar, we’ll keep on seeing advancements with wearables, home sensors and even in the body, and they all will be providing real-world data.

“We are working with our partners and the startup companies we’re invested in to redefine what’s possible, by pushing the limits and driving healthcare innovation. We’re always looking to support, and sometimes invest, in young companies that will help us transform the future of medicine.”